Biological Seed Treatment Market Overview

The Biological Seed Treatment Market will obtain a value of USD 10.2 billion and a CAGR of 9.15% between 2020-2030.

Due to benefits including enhanced nutritional quality, high yield, less crop damage, and disease resistance, the industry is seeing an increase in the kinds of biologically treated seeds. The market for biologically treated seeds is expanding due to growing environmental awareness, consumer demand for organic food production, and general attention to improving the quality of agricultural output. Biological seed treatment guarantees the quality of the treated seeds and a high germination rate, and it encourages market participants to invest a sizeable portion of their revenue in seed treatment. The biological seed treatment lowers the possibility of seeds exceeding the residual limit, a requirement for export regulations in some European countries.

Additionally, businesses are putting more emphasis on bioencapsulation since it reduces contamination during storage and transport, controls the release of bacteria into the soil, and shields soil microorganisms from biotic and abiotic challenges. Additionally, biological seed treatment is a method that is anticipated to boost return on investment. Biological seed treatment is essential for increasing production and assisting in insect protection for crops.

Global Biological Seed Treatment Market - Competitive Analysis

Highly competitive, the biological seed treatment market appears fragmented due to the presence of several well-established players. To gain a larger competitive share, innovation, mergers & acquisitions, and brand reinforcement remain key trends for industry leaders. Manufacturers strive to develop biological seed treatment designed to reduce the downtime, lower total costs, and offer longer shelf life to its end-use products. Due to the expected product extensions and product innovations, the market would witness a fierce competition in the future.

Major Players:

Players active in the global biological seed treatment market include BASF SE (Germany), Bayer AG (Germany), Syngenta AG (Switzerland), The Monsanto Company (US), Valent BioSciences LLC (US), Verdesian Life Sciences, LLC (US), Plant Health Care, Inc. (US), Precision Laboratories, LLC (US), Koppert BV (Netherlands), and Italpollina spa (Italy), among others.

Segmentation

The Biological Seed Treatment market outlook is divided into different segments to anticipate the revenues and examine the market shares of each segment throughout the forecast period. It has been segmented into two types: microbial and botanical.

The market for biological seed treatment has been segmented into cereals and grains, fruits and vegetables, oilseeds and pulses, and others based on the crop grown.

The global biological seed treatment market report has been divided into two categories based on function: seed protection and seed improvement.

The US, Canada, and Mexico have each been given their own North American biological seed treatment industry segment. The UK, Germany, France, Italy, Spain, and the rest of Europe are included in the European biological seed treatment market size classification.

Regional analysis

According to the biological seed treatment market insights, is anticipated to have the greatest revenue share in North America. Due to several market players and rising agricultural exports, Asia-Pacific is anticipated to develop at the highest CAGR over the forecast period. The region's dominance can be due to farmers' increasing preference for biologically treated seed varieties over using seeds from the most recent crop. Additionally, a rise in crop production and increased government activities in Europe's agriculture sector fuel market expansion in the region..

Recent developments

Kopper Biological Systems purchased Lençóis Paulista, So Paulo, Brazil-based Geocom in December 2020. Geocom is a leader in image geoprocessing, works in the agricultural technology industry, and was the first in Brazil to create a unique technique for using drones to apply biological agents. The company aims to improve agri-farming precision, essential for supplying biologicals to the fields.

The North American Innovation Center, Valent BioSciences, opened in August 2020, physically brings together personnel from its California technical center in Dublin and its headquarters in Walnut Creek. Now that the team has been centralized, it is simpler for them to communicate face-to-face in real-time.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013, United States of America